Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Hydrazinecarboxamide, 2-[1-(4-fluorophenyl)ethylidene]-, also known as 2-[1-(4-fluorophenyl)ethylidene]hydrazinecarboxamide, is a chemical compound with the molecular formula C9H10FN3O. It is a derivative of hydrazinecarboxamide, featuring a 4-fluorophenyl group attached to an ethylidene moiety. Hydrazinecarboxamide, 2-[1-(4-fluorophenyl)ethylidene]- is primarily used in the synthesis of various pharmaceuticals and agrochemicals, particularly as an intermediate in the production of certain pesticides and drugs. Its unique structure and properties make it a valuable component in the development of new chemical entities with potential therapeutic or pesticidal applications.

326-33-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 326-33-0 Structure
  • Basic information

    1. Product Name: Hydrazinecarboxamide, 2-[1-(4-fluorophenyl)ethylidene]-
    2. Synonyms:
    3. CAS NO:326-33-0
    4. Molecular Formula: C9H10FN3O
    5. Molecular Weight: 195.196
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 326-33-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Hydrazinecarboxamide, 2-[1-(4-fluorophenyl)ethylidene]-(CAS DataBase Reference)
    10. NIST Chemistry Reference: Hydrazinecarboxamide, 2-[1-(4-fluorophenyl)ethylidene]-(326-33-0)
    11. EPA Substance Registry System: Hydrazinecarboxamide, 2-[1-(4-fluorophenyl)ethylidene]-(326-33-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 326-33-0(Hazardous Substances Data)

326-33-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 326-33-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,2 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 326-33:
(5*3)+(4*2)+(3*6)+(2*3)+(1*3)=50
50 % 10 = 0
So 326-33-0 is a valid CAS Registry Number.

326-33-0Relevant articles and documents

Synthesis and antitubercular and antibacterial activity of some active fluorine containing quinoline–pyrazole hybrid derivatives

Nayak, Nagabhushana,Ramprasad, Jurupula,Dalimba, Udayakumar

, p. 59 - 68 (2016)

In an attempt to develop newer antitubercular and antibacterial agents against the increasing bacterial resistance, we have designed new quinoline–pyrazole analogs (8a–u) following the molecular hybridization approach. The structure of one of the final compounds, 8a was unambiguously confirmed by single crystal X-ray diffraction (SC-XRD) analysis. The target compounds were evaluated for their antitubercular activity against Mycobacterium tuberculosis and antibacterial activity against three common pathogenic bacterial strains. Four derivatives (8b, 8c, 8j and 8o) displayed significant antitubercular activity. The compounds derived from 8-trifluoromethylquinoline and 6-fluoroquinoline scaffolds with halogen substitution on the pyrazole ring exhibited superior inhibition activity than corresponding 6-methoxyquinoline analogs. The cytotoxic studies revealed that the active compounds are nontoxic to normal Vero cell lines with selectivity index values ≥10, which indicate the suitability of these compounds for further drug development. The in silico molecular docking study demonstrated strong binding affinity of the compounds with the target enzymes (InhA, CYP121 and TMPK) of M. tuberculosis. Further, the in vitro antibacterial activity of compounds 8b, 8c, 8d and 8g is comparable with that of the reference drug, Ciprofloxacin.

Synthesis of lathyrane diterpenoid nitrogen-containing heterocyclic derivatives and evaluation of their anti-inflammatory activities

Wang, Wang,Xiong, Liangliang,Li, Yutong,Song, Zhuorui,Sun, Dejuan,Li, Hua,Chen, Lixia

, (2022/01/24)

As our ongoing work on lathyrane diterpenoid derivatization, three series of lathyrane diterpenoid derivatives were designed and synthesized based combination principles, including pyrazole, thiazole and furoxan moieties. Biological evaluation indicated t

Synthesis and evaluation of antimicrobial and anticancer activities of 3-phenyl-1-phenylsulfonyl pyrazoles containing an aminoguanidine moiety

Huang, Yushan,Hu, Hongmei,Yan, Rui,Lin, Liwen,Song, Mingxia,Yao, Xiaodong

, (2020/10/15)

A series of 3-phenyl-1-phenylsulfonyl pyrazoles containing an aminoguanidine moiety was designed, synthesized, and evaluated for their antimicrobial and anticancer activities. The majority of the target compounds showed broad-spectrum antimicrobial activi

Synthesis and biological evaluation of some pyrazole derivatives, containing (Thio) semicarbazide, as dual anti-inflammatory antimicrobial agents

Liang, Zhaochang,Huang, Yuping,Wang, Shiben,Deng, Xianqing

, p. 1020 - 1030 (2019/10/28)

Background: Several series of pyrazole derivatives containing (thio) semicarbazide (4a-4h, 5a-5l, 6a-6f, 7a-7c) were designed and synthesized to screen dual inflammatory and antimicrobial activities. Methods: The products were characterized by1

Synthesis and the interaction of 2-(1H-pyrazol-4-yl)-1H-imidazo[4,5-f][1,10]phenanthrolines with telomeric DNA as lung cancer inhibitors

Liu, Jiachun,Chen, Mei,Wang, Yanli,Zhao, Xiaoyin,Wang, Sijia,Wu, Yanling,Zhang, Wen

, p. 36 - 49 (2017/04/06)

A novel series of 2-(1H-pyrazol-4-yl)-1H-imidazo[4,5-f][1,10]phenanthrolines were designed, synthesized and evaluated for their antitumor activity against lung adenocarcinoma by CCK-8 assay, electrophoretic mobility shift assay (EMSA), UV-melting study, wound healing assay and docking study. These compounds showed good inhibitory activities against lung adenocarcinoma. Especially compound 12c exhibited potential antiproliferative activity against A549?cell line with the half maximal inhibitory concentration (IC50) value of 1.48?μM, which was a more potent inhibitor than cisplatin (IC50?=?12.08?μM) and leading compound 2 (IC50?=?1.69?μM), and the maximum cell inhibitory rate being up to 98.40%. Moreover, further experiments demonstrated that compounds 12a–d can strongly interact with telomeric DNA to stabilize G-quadruplex DNA with increased ΔTm values from 12.44 to 20.54?°C at a ratio of DNA to compound 1:10. These results implied that growth inhibition of A549?cells mediated by these phenanthroline derivatives is possibly positively correlated to the fact their interaction with telomeric G-quadruplexs.

PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5- MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS

-

Page/Page column 87, (2013/03/26)

The present disclosure relates to compounds of the Formula (I): and pharmaceutically acceptable salts, as kinase modulators, compatible with the Type-II inhibition of kinases.

Some new organotin(IV) complexes of biologically important semicarbazones and thiosemicarbazones

Sharma, Shilpa,Bedi, Monica,Varshney,Varshney

, p. 41 - 50 (2012/10/29)

The present paper is a report on the synthesis of some new organotin(IV) complexes by the reactions of bis(tributyltin)oxide and semicarbazones/ thiosemicarbazones using benzene as reaction medium. Semicarbazones and thiosemicarbazones are prepared by con

UNSATURATED HETEROCYCLIC INHIBITORS OF NECROPTOSIS

-

Page/Page column 44, (2010/07/09)

The invention features new small molecule inhibitors of necroptosis. The compounds of the invention are described by Formulas (I) and (II). The invention also features pharmaceutical compositions that include compounds of Formula (I) and (II). The compounds and compositions of the invention are also featured in kits and in methods of treatment of conditions that include neurodegenerative diseases, ischemic brain and heart injuries, and head trauma.

Structure-activity relationship study of a novel necroptosis inhibitor, necrostatin-7

Zheng, Weihong,Degterev, Alexei,Hsu, Emily,Yuan, Junying,Yuan, Chengye

scheme or table, p. 4932 - 4935 (2009/05/26)

Necroptosis is a regulated caspase-independent cell death mechanism characterized by morphological features resembling non-regulated necrosis. Necrotatin-7 (Nec-7), a novel potent small-molecule inhibitor of necroptosis, is structurally distinct from previously described necrostatins (Nec-1, Nec-3, Nec-4 and Nec-5). Here, we describe a series of structural modifications and the structure-activity relationship (SAR) of the Nec-7 series for inhibiting necroptosis.

Synthesis of 3-substituted arylpyrazole-4-carboxylic acids

Lebedev,Lebedeva,Sheludyakov,Kovaleva,Ustinova,Kozhevnikov

, p. 782 - 789 (2007/10/03)

A method was suggested for preparing previously unknown 3-aryl-substituted pyrazole-4-carboxylic acids, involving Vilsmeier formylation of semicarbazones of 26 available mono- and disubstituted acetophenones and 2-acetylthiophene followed by oxidation of

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 326-33-0